Ex vivo expansion of human peripheral blood natural killer cells and cytotoxic T lymphocytes from lung cancer patients

HTM Nhung, BV Anh, TL Huyen… - Oncology …, 2018 - spandidos-publications.com
Lung cancer is the most common type of cancer with the highest cancer-associated mortality
rates worldwide, as well as in Vietnam. Numerous studies have demonstrated that higher …

Phase I clinical trial using autologous ex vivo expanded NK cells and cytotoxic T lymphocytes for cancer treatment in Vietnam

NT Liem, N Van Phong, NT Kien, BV Anh… - International Journal of …, 2019 - mdpi.com
(1) Background: Immune cell therapy recently attracted enormous attention among scientists
as a cancer treatment, but, so far, it has been poorly studied and applied in Vietnam. The …

Preparation of highly activated natural killer cells for advanced lung cancer therapy

S Xie, Z Wu, L Niu, J Chen, Y Ma… - OncoTargets and …, 2019 - Taylor & Francis
Background Natural killer (NK) cells can be used as an adoptive immunotherapy to treat
cancer patients. Purpose In this study, we evaluated the efficacy of highly activated NK …

[HTML][HTML] Development of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line

DS Bae, JK Lee - Blood research, 2014 - ncbi.nlm.nih.gov
Background Natural killer (NK) cells constantly survey surrounding tissues and remove
newly generated cancer cells, independent of cancer antigen recognition. Although there …

[HTML][HTML] Expansion and activation of natural killer cells for cancer immunotherapy

D Cho, D Campana - The Korean journal of laboratory medicine, 2009 - ncbi.nlm.nih.gov
Natural killer (NK) cells can kill a wide range of cancer cells and are a promising tool for cell
therapy of cancer. NK cells cytotoxicity is regulated by a balance between stimulatory and …

Selective expansion of human natural killer cells

BG Peng, LJ Liang, Q He, J Li, MD Lu - Ai Zheng= Aizheng …, 2005 - europepmc.org
Methods PBMCs and HFWT cells were co-cultured to expand NK cells. The cytotoxicity of
NK cells was measured using 51Cr release assay and crystal violet (CV) staining. The …

A new ex vivo method for effective expansion and activation of human natural killer cells for anti-tumor immunotherapy

H Yang, R Tang, J Li, Y Liu, L Ye, D Shao, M Jin… - Cell biochemistry and …, 2015 - Springer
Preserving the activities of natural killer (NK) cells in human peripheral blood mononuclear
cells (PBMCs) after ex vivo expansion and activation is critical for NK cell-based therapy …

The anti-tumor efficacy of natural killer (NK) cells and interleukin 2 against experimental pulmonary metastasis in rats

L Luo - Zhongguo yi xue ke xue Yuan xue bao. Acta …, 1991 - europepmc.org
Rat spleen cells with NK activity were enriched by discontinuous percoll density gradient
centrifugation. Morphologically, about 50% were large granular lymphocytes (LGL), and the …

Autologous natural killer cell-enrichment for immune cell therapy: preclinical setting phase, Shiraz experience

S Rezaeifard, Y Heike, JI Masuyama… - Iranian Journal of …, 2021 - ijaai.tums.ac.ir
Natural killer (NK) cell therapy has proven to be a promising approach for the treatment of
malignancies. Osaki method for ex-vivo autologous NK cell expansion has been recently …

Expansion of human natural killer cells ex vivo

QS Huang, Q Li, Y Huang, P Shang… - Xi bao yu fen zi Mian yi …, 2008 - europepmc.org
Aim To obtain sufficient numbers of pure and activated human primary NK cells for potential
clinical application. Methods PBMC based ex vivo expansion of natural killer cells was set …